Bio-Pharma

• 

  Milestone Pharmaceuticals randomises first patient in Phase 3 clinical trial

  August 9, 2018 • Bio-Pharma, Clinical Trials, Feature Slider, Feature-Home, Featured-Slides-Home • 130

  Milestone Pharmaceuticals, a clinical-stage cardiovascular company, has randomised the first patient in its Phase 3 clinical...

• 

  Zymeworks and Celgene to expand bispecific antibody collaboration

  April 24, 2018 • Bio-Pharma, Feature Slider, Feature-Home, Featured-Slides-Home, Uncategorized • 218

  Vancouver-based Zymeworks Inc., a biopharmaceutical company, and the biotech giant Celgene Corporation announce that they have...

• 

  Biolab – beating at the heart of it

  November 29, 2017 • Bio-Pharma, Business Focus, Feature, Feature Slider, Feature-Home, Featured-Slides-Home • 386

  There are many reasons that Mississauga has become an exceptional place to set up shop in the life sciences community. So many in...

• 

  Report says pharmocogenomics has not fulfilled its promise to developing countries

  April 14, 2014 • Bio-Pharma, Feature, Pharmacogenomics, Science Focus • 3328

  ...

• Dalton Medicinal Chemistry given notice of funding renewal from NIDA of NIH

  April 14, 2014 • Bio-Pharma, Business Focus, Management Updates • 1814

  ...

• Cardiome to distribute BRINAVESS in Spain

  March 28, 2014 • Bio-Pharma, Business Focus, Deals/M&A/Collaboration • 1953

  ...

• Aquinox Pharmaceuticals prices initial public offering

  March 11, 2014 • Bio-Pharma, Business Focus, Capital markets/Funding • 1911

  ...

• 

  BC researcher closing in on Chlamydia vaccine

  March 3, 2014 • Bio-Pharma, Drug Development, Science Focus • 1999

  ...